128 related articles for article (PubMed ID: 23207573)
1. Mathematical modelling of [¹¹C]-(+)-PHNO human competition studies.
Searle GE; Beaver JD; Tziortzi A; Comley RA; Bani M; Ghibellini G; Merlo-Pich E; Rabiner EA; Laruelle M; Gunn RN
Neuroimage; 2013 Mar; 68():119-32. PubMed ID: 23207573
[TBL] [Abstract][Full Text] [Related]
2. Imaging dopamine D3 receptors in the human brain with positron emission tomography, [11C]PHNO, and a selective D3 receptor antagonist.
Searle G; Beaver JD; Comley RA; Bani M; Tziortzi A; Slifstein M; Mugnaini M; Griffante C; Wilson AA; Merlo-Pich E; Houle S; Gunn R; Rabiner EA; Laruelle M
Biol Psychiatry; 2010 Aug; 68(4):392-9. PubMed ID: 20599188
[TBL] [Abstract][Full Text] [Related]
3. Separating dopamine D
Smart K; Gallezot JD; Nabulsi N; Labaree D; Zheng MQ; Huang Y; Carson RE; Hillmer AT; Worhunsky PD
Neuroimage; 2020 Jul; 214():116762. PubMed ID: 32201327
[TBL] [Abstract][Full Text] [Related]
4. Affinity and selectivity of [¹¹C]-(+)-PHNO for the D3 and D2 receptors in the rhesus monkey brain in vivo.
Gallezot JD; Beaver JD; Gunn RN; Nabulsi N; Weinzimmer D; Singhal T; Slifstein M; Fowles K; Ding YS; Huang Y; Laruelle M; Carson RE; Rabiner EA
Synapse; 2012 Jun; 66(6):489-500. PubMed ID: 22213512
[TBL] [Abstract][Full Text] [Related]
5. Blockade of [11C](+)-PHNO binding in human subjects by the dopamine D3 receptor antagonist ABT-925.
Graff-Guerrero A; Redden L; Abi-Saab W; Katz DA; Houle S; Barsoum P; Bhathena A; Palaparthy R; Saltarelli MD; Kapur S
Int J Neuropsychopharmacol; 2010 Apr; 13(3):273-87. PubMed ID: 19751545
[TBL] [Abstract][Full Text] [Related]
6. Age-related changes in binding of the D2/3 receptor radioligand [(11)C](+)PHNO in healthy volunteers.
Matuskey D; Worhunksy P; Correa E; Pittman B; Gallezot JD; Nabulsi N; Ropchan J; Sreeram V; Gudepu R; Gaiser E; Cosgrove K; Ding YS; Potenza MN; Huang Y; Malison RT; Carson RE
Neuroimage; 2016 Apr; 130():241-247. PubMed ID: 26876475
[TBL] [Abstract][Full Text] [Related]
7. Parametric Imaging and Test-Retest Variability of ¹¹C-(+)-PHNO Binding to D₂/D₃ Dopamine Receptors in Humans on the High-Resolution Research Tomograph PET Scanner.
Gallezot JD; Zheng MQ; Lim K; Lin SF; Labaree D; Matuskey D; Huang Y; Ding YS; Carson RE; Malison RT
J Nucl Med; 2014 Jun; 55(6):960-6. PubMed ID: 24732151
[TBL] [Abstract][Full Text] [Related]
8. Isoflurane anaesthesia differentially affects the amphetamine sensitivity of agonist and antagonist D2/D3 positron emission tomography radiotracers: implications for in vivo imaging of dopamine release.
McCormick PN; Ginovart N; Wilson AA
Mol Imaging Biol; 2011 Aug; 13(4):737-46. PubMed ID: 20680481
[TBL] [Abstract][Full Text] [Related]
9. Positron emission tomography quantification of [11C]-(+)-PHNO binding in the human brain.
Ginovart N; Willeit M; Rusjan P; Graff A; Bloomfield PM; Houle S; Kapur S; Wilson AA
J Cereb Blood Flow Metab; 2007 Apr; 27(4):857-71. PubMed ID: 17033687
[TBL] [Abstract][Full Text] [Related]
10. Within-subject comparison of [(11)C]-(+)-PHNO and [(11)C]raclopride sensitivity to acute amphetamine challenge in healthy humans.
Shotbolt P; Tziortzi AC; Searle GE; Colasanti A; van der Aart J; Abanades S; Plisson C; Miller SR; Huiban M; Beaver JD; Gunn RN; Laruelle M; Rabiner EA
J Cereb Blood Flow Metab; 2012 Jan; 32(1):127-36. PubMed ID: 21878947
[TBL] [Abstract][Full Text] [Related]
11. Dopamine (D2/3) receptor agonist positron emission tomography radiotracer [11C]-(+)-PHNO is a D3 receptor preferring agonist in vivo.
Narendran R; Slifstein M; Guillin O; Hwang Y; Hwang DR; Scher E; Reeder S; Rabiner E; Laruelle M
Synapse; 2006 Dec; 60(7):485-95. PubMed ID: 16952157
[TBL] [Abstract][Full Text] [Related]
12. High-affinity states of human brain dopamine D2/3 receptors imaged by the agonist [11C]-(+)-PHNO.
Willeit M; Ginovart N; Kapur S; Houle S; Hussey D; Seeman P; Wilson AA
Biol Psychiatry; 2006 Mar; 59(5):389-94. PubMed ID: 16373068
[TBL] [Abstract][Full Text] [Related]
13. Quantitative PET analysis of the dopamine D2 receptor agonist radioligand 11C-(R)-2-CH3O-N-n-propylnorapomorphine in the human brain.
Otsuka T; Ito H; Halldin C; Takahashi H; Takano H; Arakawa R; Okumura M; Kodaka F; Miyoshi M; Sekine M; Seki C; Nakao R; Suzuki K; Finnema S; Hirayasu Y; Suhara T; Farde L
J Nucl Med; 2009 May; 50(5):703-10. PubMed ID: 19372485
[TBL] [Abstract][Full Text] [Related]
14. Association of dopamine D
Komorowski A; Weidenauer A; Murgaš M; Sauerzopf U; Wadsak W; Mitterhauser M; Bauer M; Hacker M; Praschak-Rieder N; Kasper S; Lanzenberger R; Willeit M
Neuroimage; 2020 Dec; 223():117270. PubMed ID: 32818617
[TBL] [Abstract][Full Text] [Related]
15. A Preliminary Investigation of the Effect of Acute Alcohol on Dopamine Transmission as Assessed by [
Thiruchselvam T; Wilson AA; Boileau I; Le Foll B
Alcohol Clin Exp Res; 2017 Jun; 41(6):1112-1119. PubMed ID: 28421623
[TBL] [Abstract][Full Text] [Related]
16. Syntheses and in vitro evaluation of fluorinated naphthoxazines as dopamine D2/D3 receptor agonists: radiosynthesis, ex vivo biodistribution and autoradiography of [(18)F]F-PHNO.
Vasdev N; Seeman P; Garcia A; Stableford WT; Nobrega JN; Houle S; Wilson AA
Nucl Med Biol; 2007 Feb; 34(2):195-203. PubMed ID: 17307127
[TBL] [Abstract][Full Text] [Related]
17. Occupancy of Dopamine D3 and D2 Receptors by Buspirone: A [11C]-(+)-PHNO PET Study in Humans.
Le Foll B; Payer D; Di Ciano P; Guranda M; Nakajima S; Tong J; Mansouri E; Wilson AA; Houle S; Meyer JH; Graff-Guerrero A; Boileau I
Neuropsychopharmacology; 2016 Jan; 41(2):529-37. PubMed ID: 26089182
[TBL] [Abstract][Full Text] [Related]
18. In vivo binding of antipsychotics to D3 and D2 receptors: a PET study in baboons with [11C]-(+)-PHNO.
Girgis RR; Xu X; Miyake N; Easwaramoorthy B; Gunn RN; Rabiner EA; Abi-Dargham A; Slifstein M
Neuropsychopharmacology; 2011 Mar; 36(4):887-95. PubMed ID: 21178982
[TBL] [Abstract][Full Text] [Related]
19. In vivo quantification of regional dopamine-D3 receptor binding potential of (+)-PHNO: Studies in non-human primates and transgenic mice.
Rabiner EA; Slifstein M; Nobrega J; Plisson C; Huiban M; Raymond R; Diwan M; Wilson AA; McCormick P; Gentile G; Gunn RN; Laruelle MA
Synapse; 2009 Sep; 63(9):782-93. PubMed ID: 19489048
[TBL] [Abstract][Full Text] [Related]
20. Quantification of PET studies with the very high-affinity dopamine D2/D3 receptor ligand [11C]FLB 457: re-evaluation of the validity of using a cerebellar reference region.
Asselin MC; Montgomery AJ; Grasby PM; Hume SP
J Cereb Blood Flow Metab; 2007 Feb; 27(2):378-92. PubMed ID: 16736043
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
